Walleye Capital LLC Cor Medix Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.94 - $5.8 $62,925 - $92,631	15,971 New	15,971 $63,000
Q2 2022 Aug 08, 2022	BUY	$2.73 - $5.61 $131,040 - $269,280	48,000 New	48,000 $193,000
Q1 2022 May 16, 2022	SELL	$3.83 - $6.24 $42,896 - $69,888	-11,200 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$4.47 - $5.56 $50,064 - $62,271	11,200 New	11,200 $50,000

109

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $502M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.